Susan Blaney joins National Brain Tumor Society as Chief Scientific Officer

About the role

Susan Blaney, MD, has been appointed as the Chief Scientific Officer of the National Brain Tumor Society. She currently serves as the Director of Texas Children’s Cancer Center and Division Chief of Pediatric Oncology at Baylor College of Medicine (BCM).

Responsibilities

• Lead the scientific agenda and partnerships of the National Brain Tumor Society with the goal of accelerating the development of therapies for both pediatric and adult brain tumors.
• Develop and implement NBTS’s scientific strategy, overseeing research priorities, funding allocations, and collaborations with top academic institutions, clinical networks, government agencies, and biopharmaceutical companies.

Qualifications

• Director of Texas Children’s Cancer Center and Division Chief of Pediatric Oncology at Baylor College of Medicine (BCM)
• Vice President of Clinical and Translational Research, Associate Chair of Clinical Research for BCM’s Dan L. Duncan Comprehensive Cancer Center, and Executive Vice Chair of the Department of Pediatrics at BCM
• Member and consultant to the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Academy of Pediatrics
• Active member and chair of the National Cancer Institute (NCI)-funded Children’s Oncology Group (COG), including the Phase 1 and Pilot Consortium
• Consultant to the U.S. Food and Drug Administration’s Pediatric Oncology Drug Advisory Committee
• Prolific author with more than 220 peer-reviewed articles and co-editor of the world’s leading textbook in pediatric oncology

Benefits

Dr. Blaney’s appointment strengthens the NBTS research team, which already includes two PhDs with backgrounds in industry and government.